Dr. Xingli Wang

That's why sometimes you do notice a poor quality of the clinical trials.

It's not intentional, I would say.

It's just a lack of experience sometimes.

It's a part of a growing process.

If you look in the back of US companies, say 50 years ago, they said, do the same thing.

I would say the main ones is productivity.

Second is access to the talents.

And third one is access to the services and patients, particularly for phase one.

Most of teaching hospitals in China have phase one units nowadays.

They're designated.

Some of them have even 40 beds, which is almost impossible in US.

You don't designate your beds into a phase one study unit, but in China you do.

That's why for phase one it's going to be very quick.

At least 12 hours a day and seven or five or six or six half days a week.

I would just say, you know, for the audience, should not be putting colored glasses on when you look at China.

And we're just part of the world.

We're the same.

The same people used to work together with you.

Of course, I totally agree with you, Sam.

Well, thank you so much, Sam, for giving me the opportunities.